A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...

The PromarkerEso diagnostic blood test is intended for early detection and treatment of EAC, a form of oesophageal cancer.

Highly accurate determination of ALS using microRNA sequences will allow neurologists to make more rapid diagnoses, improving ...

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

Roche’s TAGS technology allows tests to simultaneously detect multiple respiratory viruses, including influenza A and B, RSV ...

Priced at $90, Carly is only available on the mycarly.com site. The mid-priced wireless OBD scanner includes the company’s ...

NEW YORK – The Alzheimer's Drug Discovery Foundation on Wednesday announced that it has invested $7.0 million in Alzheimer's disease diagnostic company C2N Diagnostics. Already have a 360Dx or ...

A biomarker of eight microRNAs forms a "fingerprint" of ALS in the blood, which can be detected with 98% accuracy in a ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects neurons in the brain and spinal cord.

Fulgent Genetics is transforming into a healthcare company with a focus on oncology, presenting a promising opportunity. Read ...